Chitosan microspheres for intrapulmonary administration of moxifloxacin: interaction with biomembrane models and in vitro permeation studies.
about
Micro- and nanocarrier-mediated lung targeting.Pseudomonas aeruginosa infection in cystic fibrosis lung disease and new perspectives of treatment: a review.Pharmaceutical applications of the Calu-3 lung epithelia cell line.Aspects of pulmonary drug delivery strategies for infections in cystic fibrosis--where do we stand?Recent advances in chitosan-based nanoparticulate pulmonary drug delivery.Nanocomplexes of an insulinotropic drug: optimization, microparticle formation, and antidiabetic activity in rats.Whether a novel drug delivery system can overcome the problem of biofilms in respiratory diseases?Gemcitabine-loaded chitosan microspheres. Characterization and biological in vitro evaluation.Influence of the Molecular Weight and Charge of Antibiotics on Their Release Kinetics From Gelatin Nanospheres.Transfer kinetics from colloidal drug carriers and liposomes to biomembrane models: DSC studies.Design, characterization, and aerosolization of organic solution advanced spray-dried moxifloxacin and ofloxacin dipalmitoylphosphatidylcholine (DPPC) microparticulate/nanoparticulate powders for pulmonary inhalation aerosol delivery.Ondansetron-loaded chitosan microspheres for nasal antiemetic drug delivery: an alternative approach to oral and parenteral routes.Preparation of honokiol-loaded chitosan microparticles via spray-drying method intended for pulmonary delivery.Moxifloxacin in situ gelling microparticles-bioadhesive delivery system.Release and permeation profiles of spray-dried chitosan microparticles containing caffeic acid.
P2860
Q37766234-7BC1CF86-06C8-456A-897D-F893E27FD690Q38101836-CD8A12B1-00BE-4F83-A335-435CCE3DF256Q38111427-F6AC161E-3580-4848-817B-9DDD464666EFQ38340865-06F3E007-178C-46FD-AAC4-C872D69D4013Q38903481-9DB84D84-42B6-4120-A5A8-8D211252F1CCQ38953098-197F3399-ABC4-4ACE-8D6B-A15585AADE13Q39031123-767D20E8-4CD7-4DA8-A493-F6601F6620FFQ39537445-0A54F5D0-29E8-49BE-8C32-D5EBA69E6D71Q41430876-EB87E373-5D07-4D76-ACFA-8EDCD934A8C2Q42067711-BE842B20-3CAF-47C7-B0AC-9557738B9EDBQ42961541-0BD92584-B11D-4C58-8104-14A828811BBDQ43171584-32FA2CE4-55A3-400C-80FE-38D49C440AE6Q45974678-41E509D8-9784-49FF-AAB7-66C53D908C48Q46594996-FAEAE041-0E98-4F6C-AD11-98ED2EF8243FQ51732934-64FB909B-5873-4295-A0CD-7C6E39E637EF
P2860
Chitosan microspheres for intrapulmonary administration of moxifloxacin: interaction with biomembrane models and in vitro permeation studies.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Chitosan microspheres for intr ...... d in vitro permeation studies.
@en
type
label
Chitosan microspheres for intr ...... d in vitro permeation studies.
@en
prefLabel
Chitosan microspheres for intr ...... d in vitro permeation studies.
@en
P2093
P50
P1476
Chitosan microspheres for intr ...... nd in vitro permeation studies
@en
P2093
Emanuela Crupi
Giovanni Puglisi
Ignazio Giannone
Silvana Tommasini
P304
P356
10.1016/J.EJPB.2007.05.011
P407
P577
2007-05-29T00:00:00Z